1
|
Casey L, Jinih M, MacHale J, Kirby F, O' Neill JO, Byrne R, McCarthy JF. Predictability and durability of mitral valve repair in patients with severe degenerative mitral regurgitation in medium sized centres. Ann R Coll Surg Engl 2023. [PMID: 36622239 DOI: 10.1308/rcsann.2022.0076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
INTRODUCTION Mitral valve repair (MVr) is now the treatment of choice to correct severe degenerative mitral regurgitation (MR). Repair rates vary greatly from centre to centre, and the concept of heart valve centres of excellence has been established. OBJECTIVE The purpose of this study was to see whether large international centre repair rates, and outcomes, are transferrable to medium-sized centres with an interest in mitral repair. METHODS Between 2011 and 2018, a total of 346 patients underwent mitral valve surgery by a single surgeon. Of these, 238 consecutive patients had repairs, or attempted repairs for degenerative MR, and are included in this study. RESULTS The study sample consisted of 71% male patients and had a mean age of 64.4 ± 12.3 years; 66% of the study population had concomitant procedures. The overall repair rate in this cohort is 99%. Mean follow up was 3.7 ± 1.9 years. At 5 years, the freedom from MR ≥ 3+ was 95.9 ± 1.9% and at 7 years 91.1 ± 3.8%. Freedom from reoperation at 5 years was 92.9 ± 3.7%, while the 5 years actuarial survival was 89.1 ± 3.7%. On a multivariate analysis, predischarge echo grade was associated with higher risk of future reoperation (odds ratio (OR) = 21.82, p = 0.05). Only age (OR = 1.3, p = 0.03) was predictive of long-term survival. CONCLUSIONS In specialised medium-sized heart centres, where the surgical team have undergone specialist mitral training, favourable short- and long-term outcomes are achievable with mitral repair rates similar to those from large international centres of excellence. In these heart centres, early surgery should be considered for all patients with severe degenerative MR.
Collapse
Affiliation(s)
- L Casey
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - M Jinih
- Mater Private Hospital, Dublin, Ireland
| | - J MacHale
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - F Kirby
- Blackrock Clinic, Dublin, Ireland
| | - J O O' Neill
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - R Byrne
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - J F McCarthy
- Mater Misericordiae University Hospital, Dublin, Ireland.,Mater Private Hospital, Dublin, Ireland.,Blackrock Clinic, Dublin, Ireland
| |
Collapse
|
2
|
Aktuerk D, Ali J, Badran A, Balmforth D, Bleetman D, Brown C, Suelo-Calanao R, Cartwright J, Casey L, Chiwera L, Fudulu D, Garner M, Gradinariu G, Harky A, Hussain A, Hutton S, Kew E, Loubani M, Mani K, Martin J, Rochon M, Moawad N, Mohamed S, Muretti M, Murphy G, Olivieri G, Paglinawan I, Quijano-Campos J, Rizzo V, Robertson S, Rogers L, Roman M, Salmon K, Sanders J, Talukder S, Tanner J, Vaja R, Zientara A, Green S, Miles R, Lamagni T, Harrington P. National survey of variations in practice in the prevention of surgical site infections in adult cardiac surgery, United Kingdom and Republic of Ireland. J Hosp Infect 2020; 106:812-819. [DOI: 10.1016/j.jhin.2020.09.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 09/11/2020] [Indexed: 11/25/2022]
|
3
|
Ui Dhuibhir P, Burke D, McSharry V, Mullee A, Barrett M, Casey L, Donnelly Y, Gallagher J, Higgins K, McCaffrey J, O’Donoghue N, Donoghue A, Corish C, Walsh D. PT03.01: Patient Sources of Dietary and Nutritional Information After a Cancer Diagnosis. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32553-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
4
|
Mehta V, Bahra A, Casey L, Alamgir A, VanGroningen R, Wodehouse T. EHMTI-0387. Characterization of peripheral and central sensitization in patients undergoing occipital nerve stimulator implant for intractable migraine. J Headache Pain 2014. [PMCID: PMC4181887 DOI: 10.1186/1129-2377-15-s1-m8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
|
5
|
Posse S, Zhang T, Royce M, Dayao Z, Lopez S, Sillerud L, Casey L, Eberhardt S, Lomo L, Rajput A, Russell J, Lee SJ, Bolan P. Abstract P3-03-01: 3D mapping of total choline in human breast cancer using high-speed MR spectroscopic imaging at 3T: initial experience during neoadjuvant therapy. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p3-03-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
OBJECTIVE: To assess the feasibility of quantitative high-speed MR spectroscopic imaging (MRSI) of total Choline (tCho) as an adjunct to dynamic-contrast enhanced MRI to improve lesion characterization and monitor treatment response in patients undergoing neoadjuvant chemotherapy (NAC).
METHODS: Twelve patients with infiltrating ductal carcinoma (Table 1) were studied using a clinical 3T MR scanner (Siemens, Erlangen, Germany) equipped with 8- and 16-channel breast array (Hologic Inc., Bedford, MA). Four patients were studied before NAC. Four patients were studied once during NAC. Two patients were studied before and within 2–7 days of treatment initiation. One of these patients participated in an additional scan after 5 months of treatment. Two additional patients were studied at 3 time points during NAC. Measurements were performed using PRESS prelocalized 3D Proton-Echo-Planar-Spectroscopic-Imaging (PEPSI) using TR/TE=2000ms/135ms, matrix size up to 32×16×8, voxel size = 1cc, and total acquisition time of 10 minutes (including water reference scan). Additional data were collected at TE 60 ms to enhance sensitivity for detecting tCho and J-coupled resonances. TE-averaging (8 steps, DTE: 2.5 ms) was employed to minimize gradient sideband artifacts. Quantification of tCho in reference to tissue water was performed using spectral fitting and relaxation correction.
RESULTS: Strongly elevated tCho with maximum concentration up to 5.3 mmol/kg was measured in 9 patients with enhancing lesions larger than 2 cc volume (Table 2). Decreases in tCho were measured in all four patients who were followed during neoadjuvant chemotherapy. Decreases in tCho were measurable during the first week of neoadjuvant treatment in responders, consistent with previous studies. Our preliminary data also indicate that the combination of concentration and spatial extent of detectable tCho may be the most sensitive marker of treatment response.
CONCLUSION: This study demonstrates feasibility of quantitatively mapping tCho in invasive breast carcinoma using high-speed MRSI. The long-term goals are to utilize high-speed MRSI as an early predictor of treatment failure in women undergoing neoadjuvant therapy (i.e. chemotherapy, endocrine therapy or biologic therapy) for breast cancer and to develop an improved screening protocol for high-risk patients.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P3-03-01.
Collapse
Affiliation(s)
- S Posse
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - T Zhang
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - M Royce
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - Z Dayao
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - S Lopez
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Sillerud
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Casey
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - S Eberhardt
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Lomo
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - A Rajput
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - J Russell
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - S-j Lee
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - P Bolan
- University of New Mexico School of Medicine and UNM Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| |
Collapse
|
6
|
Posse S, Royce M, Dayao ZR, Zhang T, Zhao C, Sillerud L, Lopez S, Casey L, Eberhardt SC, Lomo L, Lee SJ, Rosenberg R, Rajput A, Bolan P. P2-10-04: 3D Mapping of Total Choline in Human Breast Cancer Using High-Speed MR Spectroscopic Imaging at 3T: A Feasibility Study. Cancer Res 2011. [DOI: 10.1158/0008-5472.sabcs11-p2-10-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
PURPOSE: To assess the feasibility of quantitative high-speed MR spectroscopic imaging (MRSI) of total Choline (tCho) as an adjunct to dynamic-contrast enhanced (DCE) MRI to improve lesion characterization and monitor treatment response in patients undergoing neoadjuvant chemotherapy.
METHOD AND MATERIALS: Seven patients with biopsy-confirmed, infiltrating ductal carcinoma were studied using a clinical 3T MR scanner (Siemens Medical Solutions, Erlangen, Germany) equipped with 8- and 16-channel breast array (Hologic Inc., Bedford, MA). Measurements were performed using PRESS prelocalized 3D Proton-Echo-Planar-Spectroscopic-Imaging (PEPSI) using TR/TE=2000ms/135ms, matrix size up to 32×16x8, voxel size=1cc, and total acquisition time of 10 minutes (including water reference scan). Additional data were collected at TE 60 ms to enhance sensitivity for detecting tCho and J-coupled resonances. TE-averaging (8 steps, ΔTE: 2.5 ms) was employed to minimize gradient sideband artifacts. Quantification of tCho in reference to tissue water was performed using spectral fitting and relaxation correction.
RESULTS: Strongly elevated tCho with maximum concentration ranging from 0.3 to 4.1 mmol/kg was measured in five patients with single and multi-centric enhancing lesions larger than 2 cc volume (Table 1). The measured tCho concentration in Grade 3 tumors was higher than in lower grade untreated and treated tumors. Strong decreases in tCho concentration were measured in 2 patients undergoing neoadjuvant therapy in a follow-up scan. At short TE an additional resonance was detected that was elevated in enhancing lesions and tentatively assigned to Taurine. Two patients had lesions smaller than 2 cc with surgical clips in which tCho was not detectable due to line broadening. MRSI data sets were preferentially collected before contrast injection, since it increased spectral line width by up to 50%.
CONCLUSION: This study demonstrates feasibility of quantitatively mapping tCho in invasive breast carcinoma using high-speed MRSI. The long-term goals are to utilize high-speed MRSI as an early predictor of treatment failure in women undergoing neoadjuvant therapy (i.e. chemotherapy, endocrine therapy or biologic therapy) for breast cancer and to develop an improved screening protocol for high-risk patients. Grant support: 1RC1EB010617-01
Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P2-10-04.
Collapse
Affiliation(s)
- S Posse
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - M Royce
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - ZR Dayao
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - T Zhang
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - C Zhao
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Sillerud
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - S Lopez
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Casey
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - SC Eberhardt
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - L Lomo
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - S-J Lee
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - R Rosenberg
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - A Rajput
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| | - P Bolan
- 1University of New Mexico School of Medicine, Albuquerque, NM; University of New Mexico Cancer Center, Albuquerque, NM; New Mexico Cancer Center, Albuquerque, NM; University of Minnesota, Minneapolis, MN
| |
Collapse
|
7
|
Forde JC, O'Connor KM, Casey L, O'Brien M, Bowen S, Casey RG, Ahmed I, McDermott TE, Grainger R, Lynch TH. A rapid access diagnostic clinic for prostate cancer: the experience after one year. Ir J Med Sci 2011; 180:505-8. [PMID: 21293947 DOI: 10.1007/s11845-011-0695-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2010] [Accepted: 01/21/2011] [Indexed: 10/18/2022]
Abstract
BACKGROUND The National Cancer Control Programme is developing standards for access to diagnostics and treatment of prostate cancer. The Rapid Access Prostate Cancer (RAPC) clinic in St. James's Hospital commenced in May 2009 allowing general practitioners (GPs) more streamlined access for patients. AIMS To demonstrate that RAPC clinics allow GPs direct access to a designated cancer centre improving the prostate cancer referral process. This ultimately should reduce referral delays. METHODS A prospective analysis of all patients referred to the RAPC clinic in St. James's Hospital over a 12-month period beginning from May 2009. RESULTS Over the 12-month period 215 patients were referred to the RAPC clinic. The median age was 63 years (range 45-78). The median waiting time between referral and review at the RAPC clinic was 13 days (range 1-37). The median PSA was 7.7 μg/L (range 2.6-150). In total 199 TRUS biopsies were performed, of which 46% were positive for prostate cancer. We found that 70% of all patients had a PSA ≤ 10 μg/L and of these 32% were positive for prostate cancer. For the remaining 30% of patients who had a PSA > 10 μg/L, we found 63% were positive for prostate cancer. Regarding patients diagnosed with prostate cancer 56% have been referred for radiotherapy, 13% for surgery, 13% for hormonal treatment, 10% for active surveillance and 8% watchful waiting. CONCLUSION RAPC clinics allow GPs easier access to specialist urological opinion for patients suspected of having prostate cancer.
Collapse
Affiliation(s)
- J C Forde
- Department of Urology, St. James's Hospital, Dublin 8, Ireland.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Pabayo R, Spence J, Cutumisu N, Casey L. Individual and environmental correlates of soft drink consumption among preschool children. Can J Diabetes 2011. [DOI: 10.1016/s1499-2671(11)52208-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Avakian H, Bosted P, Burkert VD, Elouadrhiri L, Adhikari KP, Aghasyan M, Amaryan M, Anghinolfi M, Baghdasaryan H, Ball J, Battaglieri M, Bedlinskiy I, Biselli AS, Branford D, Briscoe WJ, Brooks W, Carman DS, Casey L, Cole PL, Collins P, Crabb D, Crede V, D'Angelo A, Daniel A, Dashyan N, De Vita R, De Sanctis E, Deur A, Dey B, Dhamija S, Dickson R, Djalali C, Dodge G, Doughty D, Dupre R, El Alaoui A, Eugenio P, Fegan S, Fersch R, Forest TA, Fradi A, Gabrielyan MY, Gavalian G, Gevorgyan N, Gilfoyle GP, Giovanetti KL, Girod FX, Gohn W, Gothe RW, Griffioen KA, Guidal M, Guler N, Guo L, Hafidi K, Hakobyan H, Hanretty C, Hassall N, Heddle D, Hicks K, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jawalkar SS, Jo HS, Joo K, Keller D, Khandaker M, Khetarpal P, Kim W, Klein A, Klein FJ, Konczykowski P, Kubarovsky V, Kuhn SE, Kuleshov SV, Kuznetsov V, Livingston K, Lu HY, Markov N, Mayer M, Martinez D, McAndrew J, McCracken ME, McKinnon B, Meyer CA, Mineeva T, Mirazita M, Mokeev V, Moreno B, Moriya K, Morrison B, Moutarde H, Munevar E, Nadel-Turonski P, Nasseripour R, Niccolai S, Niculescu G, Niculescu I, Niroula MR, Osipenko M, Ostrovidov AI, Paremuzyan R, Park K, Park S, Pasyuk E, Pereira SA, Perrin Y, Pisano S, Pogorelko O, Price JW, Procureur S, Prok Y, Protopopescu D, Raue BA, Ricco G, Ripani M, Rosner G, Rossi P, Sabatié F, Saini MS, Salamanca J, Salgado C, Schumacher RA, Seder E, Seraydaryan H, Sharabian YG, Sober DI, Sokhan D, Stepanyan SS, Stepanyan S, Stoler P, Strauch S, Suleiman R, Taiuti M, Tedeschi DJ, Tkachenko S, Ungaro M, Vernarsky B, Vineyard MF, Voutier E, Watts DP, Weinstein LB, Weygand DP, Wood MH, Zhang J, Zhao B, Zhao ZW. Measurement of single- and double-spin asymmetries in deep inelastic pion electroproduction with a longitudinally polarized target. Phys Rev Lett 2010; 105:262002. [PMID: 21231647 DOI: 10.1103/physrevlett.105.262002] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2010] [Indexed: 05/30/2023]
Abstract
We report the first measurement of the transverse momentum dependence of double-spin asymmetries in semi-inclusive production of pions in deep-inelastic scattering off the longitudinally polarized proton. Data have been obtained using a polarized electron beam of 5.7 GeV with the CLAS detector at the Jefferson Lab (JLab). Modulations of single spin asymmetries over the azimuthal angle between lepton scattering and hadron production planes ϕ have been measured over a wide kinematic range in Bjorken x and virtual photon squared four-momentum Q2. A significant nonzero sin2ϕ single spin asymmetry was observed for the first time indicating strong spin-orbit correlations for transversely polarized quarks in the longitudinally polarized proton.
Collapse
Affiliation(s)
- H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Chen W, Mibe T, Dutta D, Gao H, Laget JM, Mirazita M, Rossi P, Stepanyan S, Strakovsky II, Amaryan MJ, Anghinolfi M, Bagdasaryan H, Battaglieri M, Bellis M, Berman BL, Biselli AS, Bookwalter C, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Careccia SL, Carman DS, Casey L, Cole PL, Collins P, Crede V, Daniel A, Dashyan N, De Vita R, De Sanctis E, Deur A, Dhamija S, Dickson R, Djalali C, Dodge GE, Doughty D, Egiyan H, Eugenio P, Fedotov G, Fradi A, Garçon M, Gilfoyle GP, Giovanetti KL, Girod FX, Gohn W, Gothe RW, Griffioen KA, Guidal M, Hakobyan H, Hanretty C, Hassall N, Heddle D, Hicks K, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jo HS, Johnstone JR, Joo K, Keller D, Khandaker M, Khetarpal P, Kim W, Klein A, Klein FJ, Kramer LH, Kubarovsky V, Kuhn SE, Kuleshov SV, Kuznetsov V, Livingston K, Lu HY, Markov N, McCracken ME, McKinnon B, Meyer CA, Mineeva T, Mokeev V, Moreno B, Moriya K, Nadel-Turonski P, Nasseripour R, Niccolai S, Niculescu I, Niroula MR, Osipenko M, Ostrovidov AI, Park K, Park S, Pereira SA, Pogorelko O, Pozdniakov S, Price JW, Procureur S, Protopopescu D, Raue BA, Ricco G, Ripani M, Ritchie BG, Rosner G, Sabatié F, Saini MS, Salamanca J, Salgado C, Schumacher RA, Sharabian YG, Sober DI, Sokhan D, Stepanyan SS, Strauch S, Taiuti M, Tedeschi DJ, Tkachenko S, Ungaro M, Vineyard MF, Watts DP, Weinstein LB, Weygand DP, Wood MH, Yegneswaran A, Zhang J, Zhao B. Measurement of the differential cross section for the reaction gamman-->pi- p from deuterium. Phys Rev Lett 2009; 103:012301. [PMID: 19659138 DOI: 10.1103/physrevlett.103.012301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2009] [Indexed: 05/28/2023]
Abstract
We report a measurement of the differential cross section for the gamman-->pi- p process from the CLAS detector at Jefferson Laboratory in Hall B for photon energies between 1.0 and 3.5 GeV and pion center-of-mass (c.m.) angles (thetac.m.) between 50 degrees and 115 degrees. We confirm a previous indication of a broad enhancement around a c.m. energy ([sqrt]s) of 2.1 GeV at thetac.m.=90 degrees in the scaled differential cross section s7dsigma/dt and a rapid falloff in a center-of-mass energy region of about 400 MeV following the enhancement. Our data show an angular dependence of this enhancement as the suggested scaling region is approached for thetac.m. from 70 degrees to 105 degrees.
Collapse
Affiliation(s)
- W Chen
- Duke University, Durham, North Carolina 27708, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Lachniet J, Afanasev A, Arenhövel H, Brooks WK, Gilfoyle GP, Higinbotham D, Jeschonnek S, Quinn B, Vineyard MF, Adams G, Adhikari KP, Amaryan MJ, Anghinolfi M, Asavapibhop B, Asryan G, Avakian H, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Barrow S, Batourine V, Battaglieri M, Beard K, Bedlinskiy I, Bektasoglu M, Bellis M, Benmouna N, Berman BL, Biselli AS, Bonner BE, Bookwalter C, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Bültmann S, Burkert VD, Calarco JR, Careccia SL, Carman DS, Casey L, Cheng L, Cole PL, Coleman A, Collins P, Cords D, Corvisiero P, Crabb D, Crede V, Cummings JP, Dale D, Daniel A, Dashyan N, De Masi R, De Vita R, De Sanctis E, Degtyarenko PV, Denizli H, Dennis L, Deur A, Dhamija S, Dharmawardane KV, Dhuga KS, Dickson R, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Dytman S, Dzyubak OP, Egiyan H, Egiyan KS, El Fassi L, Elouadrhiri L, Empl A, Eugenio P, Fatemi R, Fedotov G, Fersch R, Feuerbach RJ, Forest TA, Fradi A, Gabrielyan MY, Garçon M, Gavalian G, Gevorgyan N, Giovanetti KL, Girod FX, Goetz JT, Gohn W, Golovatch E, Gothe RW, Graham L, Griffioen KA, Guidal M, Guillo M, Guler N, Guo L, Gyurjyan V, Hadjidakis C, Hafidi K, Hakobyan H, Hanretty C, Hardie J, Hassall N, Heddle D, Hersman FW, Hicks K, Hleiqawi I, Holtrop M, Hu J, Huertas M, Hyde-Wright CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Ito MM, Jenkins D, Jo HS, Johnstone JR, Joo K, Juengst HG, Kageya T, Kalantarians N, Keller D, Kellie JD, Khandaker M, Khetarpal P, Kim KY, Kim K, Kim W, Klein A, Klein FJ, Klusman M, Konczykowski P, Kossov M, Kramer LH, Kubarovsky V, Kuhn J, Kuhn SE, Kuleshov SV, Kuznetsov V, Laget JM, Langheinrich J, Lawrence D, Lima ACS, Livingston K, Lowry M, Lu HY, Lukashin K, Maccormick M, Malace S, Manak JJ, Markov N, Mattione P, McAleer S, McCracken ME, McKinnon B, McNabb JWC, Mecking BA, Mestayer MD, Meyer CA, Mibe T, Mikhailov K, Mineeva T, Minehart R, Mirazita M, Miskimen R, Mokeev V, Moreno B, Moriya K, Morrow SA, Moteabbed M, Mueller J, Munevar E, Mutchler GS, Nadel-Turonski P, Nasseripour R, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Niyazov RA, Nozar M, O'Rielly GV, Osipenko M, Ostrovidov AI, Park K, Park S, Pasyuk E, Paterson C, Pereira SA, Philips SA, Pierce J, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Popa I, Pozdniakov S, Preedom BM, Price JW, Prok Y, Protopopescu D, Qin LM, Raue BA, Riccardi G, Ricco G, Ripani M, Ritchie BG, Rosner G, Rossi P, Rowntree D, Rubin PD, Sabatié F, Saini MS, Salamanca J, Salgado C, Sandorfi A, Santoro JP, Sapunenko V, Schott D, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shaw J, Shvedunov NV, Skabelin AV, Smith ES, Smith LC, Sober DI, Sokhan D, Starostin A, Stavinsky A, Stepanyan S, Stepanyan SS, Stokes BE, Stoler P, Stopani KA, Strakovsky II, Strauch S, Suleiman R, Taiuti M, Taylor S, Tedeschi DJ, Thompson R, Tkabladze A, Tkachenko S, Ungaro M, Vlassov AV, Watts DP, Wei X, Weinstein LB, Weygand DP, Williams M, Wolin E, Wood MH, Yegneswaran A, Yun J, Yurov M, Zana L, Zhang J, Zhao B, Zhao ZW. Precise measurement of the neutron magnetic form factor G(M)n in the few-GeV2 region. Phys Rev Lett 2009; 102:192001. [PMID: 19518944 DOI: 10.1103/physrevlett.102.192001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2008] [Indexed: 05/27/2023]
Abstract
The neutron elastic magnetic form factor was extracted from quasielastic electron scattering on deuterium over the range Q;{2}=1.0-4.8 GeV2 with the CLAS detector at Jefferson Lab. High precision was achieved with a ratio technique and a simultaneous in situ calibration of the neutron detection efficiency. Neutrons were detected with electromagnetic calorimeters and time-of-flight scintillators at two beam energies. The dipole parametrization gives a good description of the data.
Collapse
Affiliation(s)
- J Lachniet
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA and Old Dominion University, Norfolk, Virginia 23529, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Nozar M, Salgado C, Weygand DP, Guo L, Adams G, Li J, Eugenio P, Amaryan MJ, Anghinolfi M, Asryan G, Avakian H, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Barrow S, Battaglieri M, Bedlinskiy I, Bektasoglu M, Bellis M, Benmouna N, Berman BL, Biselli AS, Blaszczyk L, Bonner BE, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Bültmann S, Burkert VD, Butuceanu C, Calarco JR, Careccia SL, Carman DS, Carnahan B, Casey L, Cazes A, Chen S, Cheng L, Cole PL, Collins P, Coltharp P, Cords D, Corvisiero P, Crabb D, Crannell H, Crede V, Cummings JP, Dale D, Dashyan N, De Masi R, De Vita R, De Sanctis E, Degtyarenko PV, Denizli H, Dennis L, Deur A, Dharmawardane KV, Dhuga KS, Dickson R, Djalali C, Dodge GE, Doughty D, Dugger M, Dytman S, Dzyubak OP, Egiyan H, Egiyan KS, El Fassi L, Elouadrhiri L, Fatemi R, Fedotov G, Feuerbach RJ, Forest TA, Fradi A, Funsten H, Garçon M, Gavalian G, Gevorgyan N, Gilfoyle GP, Giovanetti KL, Girod FX, Goetz JT, Gothe RW, Griffioen KA, Guidal M, Guillo M, Guler N, Gyurjyan V, Hadjidakis C, Hafidi K, Hakobyan H, Hanretty C, Hardie J, Hassall N, Heddle D, Hersman FW, Hicks K, Hleiqawi I, Holtrop M, Hyde-Wright CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Ito MM, Jenkins D, Jo HS, Johnstone JR, Joo K, Juengst HG, Kalantarians N, Kellie JD, Khandaker M, Kim W, Klein A, Klein FJ, Kossov M, Krahn Z, Kramer LH, Kubarovsky V, Kuhn J, Kuhn SE, Kuleshov SV, Kuznetsov V, Lachniet J, Laget JM, Langheinrich J, Lawrence D, Livingston K, Lu HY, Maccormick M, Markov N, Mattione P, McAleer S, McKinnon B, McNabb JWC, Mecking BA, Mehrabyan S, Mestayer MD, Meyer CA, Mibe T, Mikhailov K, Mirazita M, Miskimen R, Mokeev V, Moreno B, Moriya K, Morrow SA, Moteabbed M, Mueller J, Munevar E, Mutchler GS, Nadel-Turonski P, Nasseripour R, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Niyazov RA, O'Rielly GV, Osipenko M, Ostrovidov AI, Park K, Pasyuk E, Paterson C, Anefalos Pereira S, Philips SA, Pierce J, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Popa I, Pozdniakov S, Preedom BM, Price JW, Prok Y, Protopopescu D, Qin LM, Raue BA, Riccardi G, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rosner G, Rossi P, Rubin PD, Sabatié F, Salamanca J, Santoro JP, Sapunenko V, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shvedunov NV, Skabelin AV, Smith ES, Smith LC, Sober DI, Sokhan D, Stavinsky A, Stepanyan SS, Stepanyan S, Stokes BE, Stoler P, Strakovsky II, Strauch S, Taiuti M, Tedeschi DJ, Thoma U, Tkabladze A, Tkachenko S, Todor L, Ungaro M, Vineyard MF, Vlassov AV, Watts DP, Weinstein LB, Williams M, Wolin E, Wood MH, Yegneswaran A, Zana L, Zhang J, Zhao B, Zhao ZW. Search for the photoexcitation of exotic mesons in the pi+pi+pi- system. Phys Rev Lett 2009; 102:102002. [PMID: 19392105 DOI: 10.1103/physrevlett.102.102002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2008] [Indexed: 05/27/2023]
Abstract
A search for exotic mesons in the pi;{+}pi;{+}pi;{-} system photoproduced by the charge exchange reaction gammap-->pi;{+}pi;{+}pi;{-}(n) was carried out by the CLAS Collaboration at Jefferson Lab. A tagged-photon beam with energies in the 4.8 to 5.4 GeV range, produced through bremsstrahlung from a 5.744 GeV electron beam, was incident on a liquid-hydrogen target. A partial wave analysis was performed on a sample of 83 000 events, the highest such statistics to date in this reaction at these energies. The main objective of this study was to look for the photoproduction of an exotic J;{PC}=1;{-+} resonant state in the 1 to 2 GeV mass range. Our partial wave analysis shows production of the a_{2}(1320) and the pi_{2}(1670) mesons, but no evidence for the a_{1}(1260), nor the pi_{1}(1600) exotic state at the expected levels. An upper limit of 13.5 nb is determined for the exotic pi_{1}(1600) cross section, less than 2% of the a_{2}(1320) production.
Collapse
Affiliation(s)
- M Nozar
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Battaglieri M, De Vita R, Szczepaniak AP, Adhikari KP, Aghasyan M, Amaryan MJ, Ambrozewicz P, Anghinolfi M, Asryan G, Avakian H, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Batourine V, Bedlinskiy I, Bellis M, Benmouna N, Berman BL, Bibrzycki L, Biselli AS, Bookwalter C, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Bültmann S, Burkert VD, Calarco JR, Careccia SL, Carman DS, Casey L, Chen S, Cheng L, Clinton E, Cole PL, Collins P, Crabb D, Crannell H, Crede V, Cummings JP, Dale D, Daniel A, Dashyan N, De Masi R, De Sanctis E, Degtyarenko PV, Deur A, Dhamija S, Dharmawardane KV, Dickson R, Djalali C, Dodge GE, Donnelly J, Doughty D, Dugger M, Dzyubak OP, Egiyan H, Egiyan KS, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fersch R, Forest TA, Fradi A, Gabrielyan MY, Gan L, Garçon M, Gasparian A, Gavalian G, Gevorgyan N, Gilfoyle GP, Giovanetti KL, Girod FX, Glamazdin O, Goett J, Goetz JT, Gohn W, Golovatch E, Gordon CIO, Gothe RW, Graham L, Griffioen KA, Guidal M, Guler N, Guo L, Gyurjyan V, Hadjidakis C, Hafidi K, Hakobyan H, Hakobyan RS, Hanretty C, Hardie J, Hassall N, Heddle D, Hersman FW, Hicks K, Hleiqawi I, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Ito MM, Jenkins D, Jo HS, Johnstone JR, Joo K, Juengst HG, Kageya T, Kalantarians N, Keller D, Kellie JD, Khandaker M, Khetarpal P, Kim W, Klein A, Klein FJ, Klimenko AV, Konczykowski P, Kossov M, Krahn Z, Kramer LH, Kubarovsky V, Kuhn J, Kuhn SE, Kuleshov SV, Kuznetsov V, Lachniet J, Laget JM, Langheinrich J, Lawrence D, Lee T, Lesniak L, Li J, Livingston K, Lowry M, Lu HY, Maccormick M, Malace S, Markov N, Mattione P, McCracken ME, McKinnon B, Mecking BA, Melone JJ, Mestayer MD, Meyer CA, Mibe T, Mikhailov K, Mineeva T, Minehart R, Mirazita M, Miskimen R, Mochalov V, Mokeev V, Moreno B, Moriya K, Morrow SA, Moteabbed M, Munevar E, Mutchler GS, Nadel-Turonski P, Nakagawa I, Nasseripour R, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Niyazov RA, Nozar M, Osipenko M, Ostrovidov AI, Park K, Park S, Pasyuk E, Paris M, Paterson C, Pereira SA, Pierce J, Pivnyuk N, Pocanic D, Pogorelko O, Pozdniakov S, Price JW, Prok Y, Protopopescu D, Raue BA, Riccardi G, Ricco G, Ripani M, Ritchie BG, Rosner G, Rossi P, Sabatié F, Saini MS, Salamanca J, Salgado C, Sandorfi A, Santoro JP, Sapunenko V, Schott D, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shvedunov NV, Smith ES, Smith LC, Sober DI, Sokhan D, Starostin A, Stavinsky A, Stepanyan S, Stepanyan SS, Stokes BE, Stoler P, Stopani KA, Strakovsky II, Strauch S, Taiuti M, Tedeschi DJ, Teymurazyan A, Tkabladze A, Tkachenko S, Todor L, Tur C, Ungaro M, Vineyard MF, Vlassov AV, Watts DP, Wei X, Weinstein LB, Weygand DP, Williams M, Wolin E, Wood MH, Yegneswaran A, Yurov M, Zana L, Zhang J, Zhao B, Zhao ZW. Measurement of direct f0(980) photoproduction on the proton. Phys Rev Lett 2009; 102:102001. [PMID: 19392104 DOI: 10.1103/physrevlett.102.102001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2008] [Indexed: 05/27/2023]
Abstract
We report on the results of the first measurement of exclusive f_{0}(980) meson photoproduction on protons for E_{gamma}=3.0-3.8 GeV and -t=0.4-1.0 GeV2. Data were collected with the CLAS detector at the Thomas Jefferson National Accelerator Facility. The resonance was detected via its decay in the pi;{+}pi;{-} channel by performing a partial wave analysis of the reaction gammap-->ppi;{+}pi;{-}. Clear evidence of the f_{0}(980) meson was found in the interference between P and S waves at M_{pi;{+}pi;{-}} approximately 1 GeV. The S-wave differential cross section integrated in the mass range of the f_{0}(980) was found to be a factor of about 50 smaller than the cross section for the rho meson. This is the first time the f_{0}(980) meson has been measured in a photoproduction experiment.
Collapse
Affiliation(s)
- M Battaglieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Genova, 16146 Genova, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Girod FX, Niyazov RA, Avakian H, Ball J, Bedlinskiy I, Burkert VD, De Masi R, Elouadrhiri L, Garçon M, Guidal M, Jo HS, Joo K, Kubarovsky V, Kuleshov SV, MacCormick M, Niccolai S, Pogorelko O, Sabatié F, Stepanyan S, Stoler P, Ungaro M, Zhao B, Amaryan MJ, Ambrozewicz P, Anghinolfi M, Asryan G, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Batourine V, Battaglieri M, Bellis M, Benmouna N, Berman BL, Biselli AS, Blaszczyk L, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Bültmann S, Butuceanu C, Calarco JR, Careccia SL, Carman DS, Casey L, Chen S, Cheng L, Cole PL, Collins P, Coltharp P, Crabb D, Crede V, Dashyan N, De Sanctis E, De Vita R, Degtyarenko PV, Deur A, Dharmawardane KV, Dickson R, Djalali C, Dodge GE, Donnelly J, Doughty D, Dugger M, Dzyubak OP, Egiyan H, Egiyan KS, El Fassi L, Eugenio P, Fedotov G, Feldman G, Funsten H, Gavalian G, Gilfoyle GP, Giovanetti KL, Goetz JT, Gonenc A, Gothe RW, Griffioen KA, Guler N, Guo L, Gyurjyan V, Hafidi K, Hakobyan H, Hanretty C, Hersman FW, Hicks K, Hleiqawi I, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Ito MM, Jenkins D, Johnstone JR, Juengst HG, Kalantarians N, Kellie JD, Khandaker M, Kim W, Klein A, Klein FJ, Klimenko AV, Kossov M, Krahn Z, Kramer LH, Kuhn J, Kuhn SE, Lachniet J, Laget JM, Langheinrich J, Lawrence D, Lee T, Livingston K, Lu HY, Markov N, Mattione P, Mazouz M, McKinnon B, Mecking BA, Mestayer MD, Meyer CA, Mibe T, Michel B, Mikhailov K, Mirazita M, Miskimen R, Mokeev V, Moriya K, Morrow SA, Moteabbed M, Munevar E, Mutchler GS, Nadel-Turonski P, Nasseripour R, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Nozar M, Osipenko M, Ostrovidov AI, Park K, Pasyuk E, Paterson C, Anefalos Pereira S, Pierce J, Pivnyuk N, Pocanic D, Pozdniakov S, Price JW, Procureur S, Prok Y, Protopopescu D, Raue BA, Ricco G, Ripani M, Ritchie BG, Rosner G, Rossi P, Salamanca J, Salgado C, Santoro JP, Sapunenko V, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shvedunov NV, Smith ES, Smith LC, Sober DI, Sokhan D, Stavinsky A, Stepanyan SS, Stokes BE, Strakovsky II, Strauch S, Taiuti M, Tedeschi DJ, Tkabladze A, Tkachenko S, Tur C, Vineyard MF, Vlassov AV, Voutier E, Watts DP, Weinstein LB, Weygand DP, Williams M, Wolin E, Wood MH, Yegneswaran A, Zana L, Zhang J, Zhao ZW. Measurement of deeply virtual compton scattering beam-spin asymmetries. Phys Rev Lett 2008; 100:162002. [PMID: 18518188 DOI: 10.1103/physrevlett.100.162002] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2007] [Indexed: 05/26/2023]
Abstract
The beam-spin asymmetries in the hard exclusive electroproduction of photons on the proton (e p-->epgamma) were measured over a wide kinematic range and with high statistical accuracy. These asymmetries result from the interference of the Bethe-Heitler process and of deeply virtual Compton scattering. Over the whole kinematic range (x(B) from 0.11 to 0.58, Q2 from 1 to 4.8 GeV2, -t from 0.09 to 1.8 GeV2), the azimuthal dependence of the asymmetries is compatible with expectations from leading-twist dominance, A approximately a sinphi/(1+c cosphi). This extensive set of data can thus be used to constrain significantly the generalized parton distributions of the nucleon in the valence quark sector.
Collapse
Affiliation(s)
- F X Girod
- CEA-Saclay, Service de Physique Nucléaire, 91191 Gif-sur-Yvette, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Ireland DG, McKinnon B, Protopopescu D, Ambrozewicz P, Anghinolfi M, Asryan G, Avakian H, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Batourine V, Battaglieri M, Bedlinskiy I, Bellis M, Benmouna N, Berman BL, Biselli AS, Blaszczyk L, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Butuceanu C, Calarco JR, Careccia SL, Carman DS, Casey L, Chen S, Cheng L, Cole PL, Collins P, Coltharp P, Crabb D, Crede V, Dashyan N, De Masi R, De Vita R, De Sanctis E, Degtyarenko PV, Deur A, Dickson R, Djalali C, Dodge GE, Donnelly J, Doughty D, Dugger M, Dzyubak OP, Egiyan KS, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Feldman G, Fradi A, Funsten H, Garçon M, Gavalian G, Gevorgyan N, Gilfoyle GP, Giovanetti KL, Girod FX, Goetz JT, Gohn W, Gonenc A, Gothe RW, Griffioen KA, Guidal M, Guler N, Guo L, Gyurjyan V, Hafidi K, Hakobyan H, Hanretty C, Hassall N, Hersman FW, Hleiqawi I, Holtrop M, Hyde-Wright CE, Ilieva Y, Ishkhanov BS, Isupov EL, Jenkins D, Jo HS, Johnstone JR, Joo K, Juengst HG, Kalantarians N, Kellie JD, Khandaker M, Kim W, Klein A, Klein FJ, Kossov M, Krahn Z, Kramer LH, Kubarovsky V, Kuhn J, Kuleshov SV, Kuznetsov V, Lachniet J, Laget JM, Langheinrich J, Lawrence D, Livingston K, Lu HY, Maccormick M, Markov N, Mattione P, Mecking BA, Mestayer MD, Meyer CA, Mibe T, Mikhailov K, Mirazita M, Miskimen R, Mokeev V, Moreno B, Moriya K, Morrow SA, Moteabbed M, Munevar E, Mutchler GS, Nadel-Turonski P, Nasseripour R, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Niyazov RA, Nozar M, Osipenko M, Ostrovidov AI, Park K, Pasyuk E, Paterson C, Pereira SA, Pierce J, Pivnyuk N, Pogorelko O, Pozdniakov S, Price JW, Procureur S, Prok Y, Raue BA, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rosner G, Rossi P, Sabatié F, Salamanca J, Salgado C, Santoro JP, Sapunenko V, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shvedunov NV, Smith LC, Sober DI, Sokhan D, Stavinsky A, Stepanyan SS, Stepanyan S, Stokes BE, Stoler P, Strauch S, Taiuti M, Tedeschi DJ, Tkabladze A, Tkachenko S, Tur C, Ungaro M, Vineyard MF, Vlassov AV, Watts DP, Weinstein LB, Weygand DP, Williams M, Wolin E, Wood MH, Yegneswaran A, Zana L, Zhang J, Zhao B, Zhao ZW. Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett 2008; 100:052001. [PMID: 18352361 DOI: 10.1103/physrevlett.100.052001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/20/2007] [Indexed: 05/26/2023]
Abstract
We examine the results of two measurements by the CLAS collaboration, one of which claimed evidence for a Theta(+) pentaquark, while the other found no such evidence. The unique feature of these two experiments was that they were performed with the same experimental setup. Using a Bayesian analysis, we find that the results of the two experiments are in fact compatible with each other, but that the first measurement did not contain sufficient information to determine unambiguously the existence of a Theta(+). Further, we suggest a means by which the existence of a new candidate particle can be tested in a rigorous manner.
Collapse
Affiliation(s)
- D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Nasseripour R, Wood MH, Djalali C, Weygand DP, Tur C, Mosel U, Muehlich P, Adams G, Amaryan MJ, Ambrozewicz P, Anghinolfi M, Asryan G, Avakian H, Bagdasaryan H, Baillie N, Ball JP, Baltzell NA, Barrow S, Battaglieri M, Bedlinskiy I, Bektasoglu M, Bellis M, Benmouna N, Berman BL, Biselli AS, Blaszczyk L, Bouchigny S, Boiarinov S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Bültmann S, Burkert VD, Butuceanu C, Calarco JR, Careccia SL, Carman DS, Carnahan B, Casey L, Chen S, Cole PL, Collins P, Coltharp P, Crabb D, Crannell H, Crede V, Cummings JP, Dashyan N, De Masi R, De Vita R, De Sanctis E, Degtyarenko PV, Denizli H, Dennis L, Deur A, Dharmawardane KV, Dickson R, Dodge GE, Doughty D, Dugger M, Dytman S, Dzyubak OP, Egiyan H, Egiyan KS, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Feldman G, Feuerbach RJ, Funsten H, Garçon M, Gavalian G, Gilfoyle GP, Giovanetti KL, Girod FX, Goetz JT, Gordon CIO, Gothe RW, Griffioen KA, Guidal M, Guler N, Guo L, Gyurjyan V, Hadjidakis C, Hafidi K, Hakobyan H, Hakobyan RS, Hanretty C, Hardie J, Hersman FW, Hicks K, Hleiqawi I, Holtrop M, Hyde-Wright CE, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Ito MM, Jenkins D, Jo HS, Johnstone JR, Joo K, Juengst HG, Kalantarians N, Kellie JD, Khandaker M, Kim W, Klein A, Klein FJ, Klimenko AV, Kossov M, Krahn Z, Kramer LH, Kubarovsky V, Kuhn J, Kuhn SE, Kuleshov SV, Lachniet J, Laget JM, Langheinrich J, Lawrence D, Li J, Livingston K, Lu HY, Maccormick M, Markov N, Mattione P, McAleer S, McKinnon B, McNabb JWC, Mecking BA, Mehrabyan S, Melone JJ, Mestayer MD, Meyer CA, Mibe T, Mikhailov K, Minehart R, Mirazita M, Miskimen R, Mokeev V, Moriya K, Morrow SA, Moteabbed M, Mueller J, Munevar E, Mutchler GS, Nadel-Turonski P, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niroula MR, Niyazov RA, Nozar M, Osipenko M, Ostrovidov AI, Park K, Pasyuk E, Paterson C, Anefalos Pereira S, Pierce J, Pivnyuk N, Pocanic D, Pogorelko O, Pozdniakov S, Preedom BM, Price JW, Prok Y, Protopopescu D, Raue BA, Riccardi G, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rosner G, Rossi P, Sabatié F, Salamanca J, Salgado C, Santoro JP, Sapunenko V, Schumacher RA, Serov VS, Sharabian YG, Sharov D, Shvedunov NV, Smith ES, Smith LC, Sober DI, Sokhan D, Stavinsky A, Stepanyan SS, Stepanyan S, Stokes BE, Stoler P, Strakovsky II, Strauch S, Taiuti M, Tedeschi DJ, Tkabladze A, Tkachenko S, Todor L, Ungaro M, Vineyard MF, Vlassov AV, Watts DP, Weinstein LB, Williams M, Wolin E, Yegneswaran A, Zana L, Zhang B, Zhang J, Zhao B, Zhao ZW. Search for medium modifications of the rho meson. Phys Rev Lett 2007; 99:262302. [PMID: 18233570 DOI: 10.1103/physrevlett.99.262302] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/20/2007] [Indexed: 05/25/2023]
Abstract
The photoproduction of vector mesons on various nuclei has been studied using the CLAS detector at Jefferson Laboratory. The vector mesons, rho, omega, and varphi, are observed via their decay to e;{+}e;{-}, in order to reduce the effects of final-state interactions in the nucleus. Of particular interest are possible in-medium effects on the properties of the rho meson. The rho mass spectrum is extracted from the data on various nuclei, 2H, C, Fe, and Ti. We observe no significant mass shift and some broadening consistent with expected collisional broadening for the rho meson.
Collapse
Affiliation(s)
- R Nasseripour
- University of South Carolina, Columbia, South Carolina 29208, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Peng W, Zhang X, Inghirami G, Takeshita K, Pecora A, Nardone L, Casey L, Spitalny G. An anti-C3b/iC3b monoclonal antibody (Mab) as an adjuvant to rituximab killing of non-Hodgkin's lymphoma (NHL) and chronical lymphocytic leukemia (CLL) cells. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.2621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- W. Peng
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - X. Zhang
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - G. Inghirami
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - K. Takeshita
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - A. Pecora
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - L. Nardone
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - L. Casey
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| | - G. Spitalny
- Elusys Therapeutics, Inc., Pine Brook, NJ; NYU School of Medicine, New York, NY; Hackensack U. Medical Center, Hackensack, NJ
| |
Collapse
|
18
|
Smith M, Casey L, Johnson D, Gwede C, Riggin OZ. Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Oncol Nurs Forum 2001; 28:855-62. [PMID: 11421145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
PURPOSE/OBJECTIVES To determine whether music moderates the level of anxiety that patients experience during radiation therapy. DESIGN Experimental, longitudinal, random assignment to music or no music therapy. SETTING Urban radiation oncology center in a Department of Veterans Affairs hospital in the southeastern United States. SAMPLE Forty-two men (19 in the experimental group, 23 in the control group) aged 39-80 years (74% white, 12% African American, 12% Hispanic, and 2% other) receiving definitive external beam radiation therapy for pelvic or abdominal malignancies. METHODS Patients in the experimental group listened to music of their choice provided via audiotapes and headphones before and during their simulation and daily treatments for the duration of the planned course of therapy. The control group received standard care. The State-Trait Anxiety Inventory was administered initially to participants in both groups at the time of evaluation (time 1), post-simulation (time 2), at the end of the first week (time 3), at the end of the third week (time 4), and at the end of the fifth week or end of radiation therapy (time 5). MAIN RESEARCH VARIABLE State anxiety. FINDINGS No significant difference existed between the two groups to suggest that music moderated the level of anxiety during radiotherapy. However, post-hoc analyses identified changes and trends in state anxiety scores, suggesting a possible benefit of music therapy during radiotherapy. CONCLUSIONS Despite a lack of group differences, early intervention with music therapy for patients with high levels of anxiety may be beneficial. IMPLICATIONS FOR NURSING PRACTICE Nurses and other clinicians may administer state anxiety scales at the initial visit or prior to pretreatment radiation planning (simulation). Individuals who have high state anxiety scores may receive nursing interventions tailored to reduce anxiety during simulation and the early part of radiotherapy.
Collapse
Affiliation(s)
- M Smith
- Geriatric Psychiatry Department, James A. Haley Veterans Affairs Medical Center, Tampa, USA
| | | | | | | | | |
Collapse
|
19
|
Zachariah B, Jacob SS, Gwede C, Cantor A, Patil J, Casey L, Zachariah AB. Effect of fractionated regional external beam radiotherapy on peripheral blood cell count. Int J Radiat Oncol Biol Phys 2001; 50:465-72. [PMID: 11380235 DOI: 10.1016/s0360-3016(00)01587-x] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE The purpose of this study was to assess the need for obtaining weekly complete blood count (CBC) values and to identify the pattern of changes in CBC during regional conventional fractionated radiotherapy. METHODS AND MATERIALS A retrospective analysis of CBC data on 299 adult cancer patients who received definitive conventional radiotherapy to head and neck (n = 95), chest (n = 96), and pelvis (n = 108) was performed. Temporal patterns and magnitude of change in white blood cells, neutrophils, lymphocytes, and platelets during radiotherapy were examined. RESULTS There were statistically significant declines in all counts, albeit not clinically significant. Notable differences between disease sites were found. The greatest weekly interval change in counts occurred during the first week of radiotherapy for all groups of patients. The mean WBC nadir values during treatment were 5.8 for head & neck, 6.8 for chest, and 5.4 for pelvis. The nadirs for all counts occurred toward the middle-to-end of radiotherapy. Lymphocytes were found to be more sensitive to radiotherapy than other leukocyte subcomponents. CONCLUSION Our study suggests that weekly CBC monitoring is not necessary for all patients undergoing standard fractionated radiotherapy. Baseline blood counts may be used to determine an optimal schedule for monitoring CBCs in patients receiving conventional radiation alone. Reduced monitoring of CBC may result in significant financial savings.
Collapse
Affiliation(s)
- B Zachariah
- James A. Haley Veterans Administration Hospital, Tampa, FL, USA.
| | | | | | | | | | | | | |
Collapse
|
20
|
Sharma KC, Stevens D, Casey L, Kesten S. Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers. Chest 2000; 118:1042-8. [PMID: 11035675 DOI: 10.1378/chest.118.4.1042] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
BACKGROUND Systemic corticosteroids are known to alter cell-mediated immunity (CMI). However, the effects of inhaled steroids on CMI are unclear. We therefore sought to assess CMI following high-dose inhaled steroids in healthy subjects. METHODS Ten healthy nonasthmatic subjects self-administered fluticasone propionate (FP), 440 microg bid, with a spacer device. CMI was assessed by delayed hypersensitivity skin testing to multiple antigens and in vitro by phytohemagglutinin (PHA) stimulation of peripheral blood T lymphocytes. Percentages of CD3(+), CD4(+), and CD3(+)CD8(+) cells expressing CD69(+) were determined by three-color flow cytometry. Studies were conducted before and after 4 weeks of FP treatment. RESULTS After 4 weeks of FP treatment, two of nine subjects became anergic, whereas six of nine subjects had reduced skin responses (one subject was excluded). Mean total skin test score fell from 18.4+/-10.9 to 9.1 +/-7.2 mm (p = 0.02). There was a decline in tuberculin responses in all four subjects who were positive prior to FP treatment. Following FP treatment, the percentage of unstimulated (from control subjects receiving saline solution) CD3(+)CD4(+)CD69(+) cells declined from 14.8+/-4.2% to 8. 5+/-4.6% (p = 0.02) and the CD3(+)CD8(+)CD69(+) cells decreased from 29.7+/-12.7% to 17.1 +/-5.0% (p = 0.007). PHA stimulation produced significant increases in the percentage of CD3(+)CD4(+)CD69(+) cells before and after FP treatment (67.0+/-9.1%, p<0.02 before FP; 55.4+/-17.0%, p<0.02 after FP), and in the percentage of CD3(+)CD8(+)CD69(+) cells before and after treatment (79.7+/-9.3%, p<0.03 before FP; 71.2+/-11.4%, p = 0. 008 after FP). CONCLUSIONS High doses of FP suppress the proportion of activated circulating T cells but do not affect the ability of T cells to respond to direct stimulation with PHA. However, depression of skin test responses to antigens following treatment with FP suggests an impairment of in vivo clinical manifestations of T-cell activation by a mechanism that requires further investigation.
Collapse
Affiliation(s)
- K C Sharma
- Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA
| | | | | | | |
Collapse
|
21
|
Barroso J, McMillan S, Casey L, Gibson W, Kaminski G, Meyer J. Comparison between African-American and white women in their beliefs about breast cancer and their health locus of control. Cancer Nurs 2000; 23:268-76. [PMID: 10939174 DOI: 10.1097/00002820-200008000-00003] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The purpose of this study was to examine the health beliefs of African-American and white women about breast cancer and locus of control, using the health belief model and the health locus of control construct. The Health Screening Questionnaire, developed by Sugarek, Deyo, and Holmes, was used to collect self-report data about health beliefs related to breast cancer and health locus of control. Participants included 197 white and 152 African-American women, between the ages of 19 and 93, recruited from various settings in central Florida. Significant differences were found between the two groups on all of the health beliefs about cancer items. The African-American women were significantly more likely to believe in chance, or to depend on powerful others for their health. Perceived susceptibility to cancer, doubts about the value of early diagnosis, and beliefs about the seriousness of breast cancer all were significantly associated with powerful other scores among African-American women. There was no relation between health beliefs and years of education for African-American women, but for white women, those with the least education were more likely to believe that death was inevitable with a cancer diagnosis. These results add to the information needed for the development of effective programs aimed at increasing breast cancer screening among African-American women.
Collapse
Affiliation(s)
- J Barroso
- Department of Adult & Geriatric Health, University of North Carolina, Chapel Hill School of Nursing 27599-7460, USA.
| | | | | | | | | | | |
Collapse
|
22
|
Trotti A, Johnson DJ, Gwede C, Casey L, Sauder B, Cantor A, Pearlman J. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys 1998; 42:257-61. [PMID: 9788402 DOI: 10.1016/s0360-3016(98)00224-7] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
PURPOSE/OBJECTIVE A review of available head and neck quality of life (QOL) instruments reveals them to inadequately address important radiation related side effects, or to be too cumbersome for routine use. The purpose of this study was to develop a head and neck disease specific module as a companion to the previously developed quality of life - radiation therapy instrument (QOL-RTI). The goal was to create a more complete, yet concise, head and neck site-specific module geared toward patients receiving radiation therapy for head and neck cancer. METHODS AND MATERIALS This exploratory study included 34 consecutive patients undergoing definitive radiotherapy over a 6-7 week course (60-79.8 Gy). We developed and administered a 14-item questionnaire to all eligible patients treated with radiotherapy for head and neck cancer who were not already registered in another research study assessing quality of life (e.g., RTOG). During the treatment period, the QOL-RTI general tool and the head and neck (H&N) module were administered as follows: at baseline, at week four (for test-retest), and at the end of the treatment period. For validation purposes the QOL-RTI/H&N was compared to the functional assessment cancer tool head and neck (FACT-H&N) questionnaire. The FACT-H&N was administered one time at week 4, on the same day as the QOL-RTI/H&N. This report includes the treatment phase of the study (during the course of radiation). RESULTS Mean age was 62 years (range 40-75). Internal consistency of the module was satisfactory (Chronbach's alpha = 0.85). Test-retest yielded a correlation coefficient of 0.90 (p < 0.001). Concurrent validity, established by comparing the module to the FACT/H&N , yielded a correlation coefficient of 0.85. Significant changes in quality of life scores during a course of radiation was noted for both general quality of life tool and the site specific module. For the head and neck module, the difference in the mean baseline (7.17) and end of treatment scores (4.20) was 2.94, or 42% change (p < 0.0001). A smaller, yet still significant, difference in scores was seen in the general QOL tool (22 % change, p = 0.001). Item analysis of the module revealed statistically significant (p < 0.05) worsening in quality of life scores in the following areas: pain in throat, swallowing difficulty (meat/bread and liquids), changes in mucous and saliva, changes in taste, difficulty chewing, trouble with coughing, and speech difficulties. Items that were not significant were pain in the mouth, and appearance. CONCLUSION These initial results suggest that the H&N companion module to the QOL-RTI is a valid and reliable tool that is responsive to changes in QOL during a course of H&N radiation therapy. This tool differs from existing H&N tools by including specific assessments of mucous, saliva, taste, cough, and local pain in a concise format. Significant changes in QOL scores were noted in all of these items. Evaluation of the tool in the post-treatment period (follow-up) is ongoing.
Collapse
Affiliation(s)
- A Trotti
- Division of Radiation Oncology, and the Biostatistics Core, University of South Florida, James A. Haley VA Medical Center, Tampa, USA.
| | | | | | | | | | | | | |
Collapse
|
23
|
Liu Y, Casey L, Pike LJ. Compartmentalization of phosphatidylinositol 4,5-bisphosphate in low-density membrane domains in the absence of caveolin. Biochem Biophys Res Commun 1998; 245:684-90. [PMID: 9588175 DOI: 10.1006/bbrc.1998.8329] [Citation(s) in RCA: 88] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
In cells that exhibit caveolae, the hormone-sensitive pool of PtdIns 4,5-P2 is localized in a low density, caveolin-enriched membrane fraction (1). Neuro 2a cells do not express caveolin. Nonetheless, the PtdIns 4,5-P2 in these cells is compartmentalized in a low density, detergent-insoluble domain that also contains other signaling-related molecules. Compartmentalization of PtdIns 4,5-P2 was observed regardless of whether Triton X-100-containing or detergent-free methods were used to prepare the membranes. However, the partitioning of receptor tyrosine kinases and GPI-anchored proteins into the low density domains was dependent upon the method of membrane preparation. Treatment of Neuro 2a cells with cyclodextrin delocalized the PtdIns 4,5-P2 and inhibited hormone-stimulated PtdIns turnover. These results suggest that compartmentalization of PtdIns 4,5-P2 does not require caveolin but is necessary for the proper functioning of phosphoinositide-based signaling.
Collapse
Affiliation(s)
- Y Liu
- Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | | | | |
Collapse
|
24
|
Zachariah B, Gwede C, Patil J, Casey L, Cantor A. Effect of fractionated regional external beam radiotherapy on peripheral blood cells. Int J Radiat Oncol Biol Phys 1998. [DOI: 10.1016/s0360-3016(98)80614-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Zachariah B, Balducci L, Venkattaramanabalaji GV, Casey L, Greenberg HM, DelRegato JA. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997; 39:1125-9. [PMID: 9392554 DOI: 10.1016/s0360-3016(97)00552-x] [Citation(s) in RCA: 131] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
PURPOSE To profile cancer patients aged 80 and older undergoing radiotherapy and to study the tumor response and side effects of therapy. METHODS AND MATERIALS We retrospectively analyzed the records of patients aged 80 and older who received radiation therapy at James A. Haley Veterans Hospital and H. Lee Moffitt Cancer Center between 1988 and 1995. A total of 203 patients aged 80-94 received radiotherapy during this period. Treatment sites included head and neck [50], breast [16], chest [37], pelvis [53], and miscellaneous [39]. Age, treatment site, field size, total dose, response to treatment, treatment interruptions, incidence and severity of weight loss, myelosuppression, diarrhea, mucositis, dermatitis, and follow-up status are assessed using our departmental records and hospital tumor registry. RESULTS Of 191 patients evaluated, 179 (94%) completed the treatment without serious complications. A total of 195 sites were irradiated. Twelve patients (6%) required interruption of the treatment. Therapeutic responses were seen in 86 out of 112 patients (77%) treated with curative intent (with 67% complete response) and in 67 out of 83 patients (81%) treated with palliative intent. The causes of treatment interruptions included weight loss from diarrhea, dysphagia, and progressive disease. Treatment interruptions were more likely in patients treated with large treatment fields. In patients treated for upper aero-digestive tract cancer, Grade 3 and 4 mucositis was noted in 20 and 2% of patients, respectively. Grade 1 and 2 enteritis was noted in 43% of patients treated for pelvic malignancies. Grade 3 dermatitis was noted only in 2% of patients. CONCLUSION Radiotherapy is highly effective and well tolerated by the oldest old. Age is not a contraindication to aggressive radiotherapy.
Collapse
Affiliation(s)
- B Zachariah
- H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, James A. Haley Veterans Hospital, Tampa 33612, USA
| | | | | | | | | | | |
Collapse
|
26
|
Siziopikou KP, Ahn MC, Casey L, Silver M, Harris JE, Braun DP. Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes. Cancer Immunol Immunother 1997; 45:29-36. [PMID: 9353424 PMCID: PMC11037803 DOI: 10.1007/s002620050397] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/1997] [Accepted: 06/11/1997] [Indexed: 02/05/2023]
Abstract
It has been reported that the in vitro development of tumoricidal function in alveolar macrophages from lung cancer patients is reduced significantly when compared to that in peripheral blood monocytes from the same patients or alveolar macrophages from control patients. In the present investigation, a method for potentiating the development of tumoricidal function in alveolar macrophages from lung cancer patients is described. This method, which relies on priming the macrophages with purified, allogeneic peripheral blood lymphocytes from normal donors, could not be demonstrated when autologous lymphocytes from lung cancer patients were used in the priming coculture. The augmentation of tumoricidal function appears to be mediated by one or more soluble factors, since supernatants from cocultures of alveolar macrophages and allogeneic peripheral blood lymphocytes could enhance the cytotoxic function of freshly obtained alveolar macrophages. Furthermore, it appears that NK cells are necessary for this effect, since depletion of CD56+/CD57+ cells from allogeneic lymphocytes eliminated their capacity to enhance alveolar macrophage cytotoxic function. The augmentation of cytotoxic function elicited in alveolar macrophages by this method was not associated with changes in the secretion of tumor necrosis factor alpha, or interleukin 1 beta.
Collapse
Affiliation(s)
- K P Siziopikou
- Section of Medical Oncology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA
| | | | | | | | | | | |
Collapse
|
27
|
Ahn MC, Siziopikou KP, Plate JM, Casey L, Silver M, Harris JE, Braun DP. Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6. Cancer Immunol Immunother 1997; 45:37-44. [PMID: 9353425 PMCID: PMC11037664 DOI: 10.1007/s002620050398] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/1997] [Accepted: 06/11/1997] [Indexed: 02/07/2023]
Abstract
Previous studies have demonstrated that alveolar macrophages from lung cancer patients are impaired in their ability to develop tumoricidal function when stimulated by activators such as interferon gamma + lipopolysaccharide. However, these same macrophages have been shown to develop significant tumoricidal function when precultured with macrophage-depleted allogeneic peripheral blood lymphocytes from normal donors, an effect that was lost by the elimination of natural killer cells from the allogeneic lymphocyte population. In the present study, the effect of each activation condition on the expression of mRNA for interleukin-1 alpha (IL-1 alpha), IL-1 beta, tumor necrosis factor alpha (TNF alpha) and IL-6 was determined using reverse transcription/polymerase chain reaction. The results show that the non-permissive activation condition is associated with the expression of mRNA for IL-6 while the permissive activation condition is not. Antibodies against IL-6 were subsequently shown to permit the development of tumoricidal function in alveolar macrophages stimulated with interferon gamma + lipopolysaccharide while IL-6 protein was shown to inhibit the stimulatory action of allogeneic lymphocytes on the development of tumoricidal function in the same alveolar macrophages. Neither the permissive (i.e. allogeneic lymphocyte stimulation) nor the non-permissive (i.e. interferon gamma + lipopolysaccharide) activation condition had any effect on the capacity of alveolar macrophages from lung cancer patients to express mRNA for IL-1 alpha, IL-1 beta or TNF alpha. These results show that IL-6 can regulate the ability of alveolar macrophages from lung cancer patients to be stimulated by interferon gamma + lipopolysaccharide to develop significant tumoricidal function. They also show that allogeneic lymphocytes have the capacity to down-regulate IL-6 mRNA synthesis by alveolar macrophages thereby permitting the development and/or expression of macrophage tumoricidal function.
Collapse
Affiliation(s)
- M C Ahn
- Section of Medical Oncology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA
| | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
Caveolae are small, plasma membrane invaginations that have been implicated in cell signaling. In A431 cells, approximately half of the total cellular phosphatidylinositol 4,5-bisphosphate (PtdIns 4, 5-P2) was found to be localized in low density, Triton-insoluble membrane domains enriched in caveolin. Treatment of cells with either epidermal growth factor or bradykinin for 5 min at 37 degrees C resulted in approximately a 50% decrease in this caveolar PtdIns 4,5-P2 with no change in the levels of plasma membrane PtdIns 4,5-P2. These data suggest that the PtdIns 4,5-P2 present in cells is largely compartmentalized and that the caveolar PtdIns 4,5-P2 is subject to hydrolysis by hormone-stimulated phospholipase C. As growth factor receptors, seven transmembrane domain receptors, heterotrimeric G proteins, and the inositol trisphosphate receptor have all been shown to be enriched in caveolae, these findings suggest that both the generation and response to inositol trisphosphate is highly compartmentalized within the cell.
Collapse
Affiliation(s)
- L J Pike
- Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | | |
Collapse
|
29
|
Abstract
Psychological studies of superordinates have generally treated them as equivalent. However, many languages distinguish mass superordinates (e.g., clothing) from count superordinates (e.g., vehicle). In the present paper, experimental evidence is presented which suggests that the two types of superordinates are conceptually distinct as well. One study showed that the members of mass superordinates more often co-occur. A second study showed that people more often interact with the members of mass superordinates in temporal proximity whereas people primarily interact with single members of count superordinates on a specific occasion. Also, properties that characterize an individual are a more salient aspect of count superordinates. These findings imply that mass superordinates refer to unindividuated groups of objects, united by spatial and functional contiguity. Two other studies supported this hypothesis by showing that the class inclusion relation between a single object and a category is stronger for count superordinates. Taken together, the findings suggest that mass superordinates are not true taxonomic categories. We relate the findings to previous views of superordinates and to the count/mass distinction in general.
Collapse
Affiliation(s)
- E J Wisniewski
- Department of Psychology, Northwestern University, Evanston, IL 60208-2710, USA.
| | | | | |
Collapse
|
30
|
McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Cheng SC, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel F. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996; 156:799-805. [PMID: 8615714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND Evidence-based guidelines for the treatment of patients with acute myocardial infarction (AMI) have been published and disseminated by the American College of Cardiology and the American Heart Association. Few studies have examined the rates of adherence to these guidelines in eligible populations and the influence of age and gender on highly effective AMI treatments in community hospital settings. METHODS Medical records of 2409 individuals admitted to 37 Minnesota hospitals between October 1992 and July 1993 for AMI, suspected AMI, or rule-out AMI, and meeting electrocardiographic, laboratory, and clinical criteria suggestive of AMI were reviewed to determine the proportion of eligible patients who received thrombolytic, beta-blocker, aspirin, and lidocaine hydrochloride therapy. The effects of patient age, gender, and hospital teaching status on the use of these treatments were estimated using logistic regression models. RESULTS Eligibility for treatment ranged from 68% (n=1627) for aspirin therapy, 38% (n=906) for lidocaine therapy, and 30% (n=734) for thrombolytic therapy to 19% (n=447) for beta-blocker therapy. Seventy-two percent of patients eligible to receive a thrombolytic agent received this therapy; 53% received beta-blockers; 81% received aspirin; and 88% received lidocaine. Among patients ineligible for lidocaine therapy (n=1503), 20% received this agent. Use of study drugs was lower among eligible elderly patients, especially those older than 74 years (thrombolytic agent: odds ratio, 0.2; 95% confidence interval, 0.1 to 0.4; aspirin: odds ratio, 0.4, 95% confidence interval, 0.3 to 0.6; beta-blocker: odds ratio, 0.4; 95% confidence interval, 0.2 to 0.8). Female gender was associated with lower levels of aspirin use among eligible patients (odds ratio, 0.7; 95% confidence interval, 0.6 to 0.9); and there was a trend toward lower levels of beta-blocker and thrombolytic use among eligible women. CONCLUSIONS Use of lifesaving therapies for eligible patients with AMI is higher than previously reported, particularly for aspirin and thrombolytic use in nonelderly patients. Lidocaine is still used inappropriately in a substantial proportion of patients with AMI. Increased adherence to AMI treatment guidelines is required for elderly patients and women.
Collapse
Affiliation(s)
- T J McLaughlin
- Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Mass, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Casey L, Gillanders WR, Oprandi AM, Gilchrist VJ, Iverson D. Economic analysis of family practice residency programs: a report from the Northeastern Ohio Network. Fam Med 1995; 27:424-30. [PMID: 7557004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
BACKGROUND The financial impact of a family practice residency program on a sponsoring institution is poorly understood. This study intended to describe as fully as possible all the expenses and revenues from five community-based family practice residency programs in northeastern Ohio. METHODS Direct and indirect expenses, revenues, and demographics were evaluated for 1992. Similarities and differences among the participating programs were examined. RESULTS Overall expenses per resident were similar in all five programs, with a range from $162,000 to $203,000. Revenues reflected the number of residents in the program, although collection ratios varied. Inpatient collections ranged from 53%-76% and outpatient collections ranged from 60%-76%. An average of 30% of graduates from the past 10 years were on the active medical staff of their sponsoring institution, with a range of 21%-36%. CONCLUSION Based on the expenses, revenues collected, and reasonable assumptions made about cost of care in the hospital setting, the family practice residencies are probably a break-even operation, excluding the benefit of providing primary care physicians to the community.
Collapse
Affiliation(s)
- L Casey
- Aultman Hospital, Canton, Ohio, USA
| | | | | | | | | |
Collapse
|
32
|
Affiliation(s)
- B Zachariah
- James A. Haley Veterans Hospital, Tampa, FL 33612, USA
| | | | | |
Collapse
|
33
|
Abstract
This article focuses on the skills, attitudes, and goals required for effective history-taking during comprehensive health assessment in the primary care setting. The approach presented is characterized as "patient-centered" in that the woman is engaged in the problem-solving process. Specific communication skills are discussed, and attitudes and goals that enable primary care providers to adopt a patient-centered approach to relationship-centered care are included.
Collapse
Affiliation(s)
- M Quirk
- University of Massachusetts Medical School, Worcester, USA
| | | |
Collapse
|
34
|
Abstract
Primary small cell carcinoma of the prostate (SCCP) is rare. Natural history of this tumor is similar to that of bronchogenic small cell carcinoma. A majority of patients with SCCP have distant metastasis at presentation. Because the disease is rapidly fatal, the incidence of brain metastasis from SCCP is not known. A case of primary SCCP with multiple subcutaneous and lymph node metastases is presented. The patient failed to respond to systemic hormone therapy but had a near complete response to multiple agent chemotherapy consisting of cyclophosphamide, adriamycin, and vincristine. Multiple brain metastases subsequently developed, and he responded poorly to cranial irradiation. The clinical behavior of this cancer being similar to that of bronchogenic small cell carcinoma, it supports the recommendation of computerized axial tomography of the brain to be included in the staging workup of patients with SCCP. Prophylactic cranial irradiation might be of value in patients with a complete response to chemotherapy.
Collapse
Affiliation(s)
- B Zachariah
- Department of Radiation Oncology, H. Lee Moffitt Cancer Center, University of South Florida, Bay Pines
| | | | | | | | | |
Collapse
|
35
|
Abstract
The purpose of this research was to develop a quality of life (QOL) tool that would help to reveal any physical, mental or emotional changes patients may experience while receiving radiation therapy. Research focusing on quality of life during radiation therapy is in its infancy. Although many tools to measure QOL have been developed, until very recently few had been geared specifically toward those receiving radiation therapy. In addition to a radiation-specific instrument, the goal was to develop a multidimensional measure that would be short in length and could be completed by the patient in 15 min or less. This new Quality of Life Radiation Therapy Instrument (QOL-RTI) is a visual analogue scale with 24 questions and is not site specific. Twenty-one patients with various diagnoses and treatment sites completed the questionnaire at baseline and then weekly during the course of radiation therapy. The internal consistency of the instrument (Cronbach's alpha) was 0.87. At baseline each patient also was asked to complete the Ferran's and Powers QLI Cancer Version 6 (QLIC); the correlation between the QLIC and the QOL-RTI was 0.47. These results are based on a small number of patients, but initial efforts in creating an instrument that is quick and easy for patients to complete have been encouraging. An additional 70-80 patients are now being entered into a study using the QOL-RTI to further evaluate reliability and validity.
Collapse
Affiliation(s)
- D J Johnson
- University of South Florida, Division of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa 33612
| | | | | |
Collapse
|
36
|
Braun DP, Ahn MC, Harris JE, Chu E, Casey L, Wilbanks G, Siziopikou KP. Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism. Cancer Res 1993; 53:3362-8. [PMID: 8391924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The sensitivity of cancer patient macrophages from different anatomical sites to arachidonic acid metabolism was investigated in tumor cell cytotoxicity assays. Alveolar macrophages and peripheral blood monocytes from 13 non-small cell lung cancer patients, peritoneal macrophages and peripheral blood monocytes from 13 ovarian cancer patients, and comparable macrophages from control patients with nonmalignant lung or gynecological diseases were tested. Inhibitors of either the cyclooxygenase pathway or the lipoxygenase pathway together with specific metabolites of each pathway were used to evaluate how these different macrophage populations are regulated by eicosanoids. In addition, metabolic studies were performed to compare directly the arachidonic acid metabolism of macrophages obtained from these different anatomical locations. The results demonstrate that the peripheral blood monocytes from lung cancer and ovarian cancer patients and the peritoneal macrophages from ovarian cancer patients are sensitive to cyclooxygenase inhibition; this was not seen with comparable macrophages from the relevant control patients. Sensitivity to modulation by cyclooxygenase inhibition correlated with increased cyclooxygenase metabolism and with the capacity of prostaglandin to mediate suppression of tumoricidal function in these populations of cancer patient macrophages. In contrast, alveolar macrophages from cancer patients were not sensitive to either cyclooxygenase inhibition or to prostaglandin-mediated suppression. No such differential influences were revealed for the lipoxygenase pathway of arachidonic acid metabolism in any macrophage population tested. Thus, eicosanoids, particularly those of the cyclooxygenase pathway, can be a critical immunoregulatory feature of certain tumor microenvironments.
Collapse
Affiliation(s)
- D P Braun
- Section of Medical Oncology, Rush Medical College, Chicago, Illinois 60612
| | | | | | | | | | | | | |
Collapse
|
37
|
Blount BW, Krober MS, Gloyd SS, Kozakowski M, Casey L. Nutritional status of rural Bolivian children. Mil Med 1993; 158:367-70. [PMID: 8361590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
While providing health care in rural Bolivia, 349 children under 4 years old were seen. Height and weight were measured and demographic data obtained. The purpose was to describe the prevalence of malnutrition and its associated socioeconomic factors. The sample included Mataco Indians and Bolivians of European or of mixed descent. Using international standards, 21% of the children had weight below the fifth percentile for age; 27% had height below the fifth percentage for age; 17% were below the fifth percentile for weight/height. Malnutrition was more common in younger children (peak prevalence in 1-2 year olds). Malnutrition was associated with race and water source, but not with family size, literacy, immunizations, meals per day, or deaths in family. Attempts to improve nutrition should focus on the youngest children.
Collapse
Affiliation(s)
- B W Blount
- Department of Family Practice, Eisenhower Army Medical Center, Fort Gordon, GA 30905
| | | | | | | | | |
Collapse
|
38
|
Abstract
The capacity of alveolar macrophages and peripheral blood monocytes from patients with non-small cell lung cancer to develop tumoricidal function after in vitro stimulation with different macrophage activators was investigated. Alveolar macrophages were found to be impaired in their ability to develop cytotoxic activity compared with either the peripheral blood monocytes from the same patients or alveolar macrophages from patients with nonmalignant lung disorders. This result was observed consistently under diverse culture conditions and with different macrophage activators including gamma-interferon (gamma-IFN), granulocyte-macrophage colony-stimulating factor (GM-CSF), phorbol myristate acetate, or endotoxin. The impairment in tumoricidal function observed in alveolar macrophages was not associated with reduced target cell binding compared to peripheral blood monocytes. Alveolar macrophages from patients with lung cancer were found to secrete significantly greater amounts of tumor necrosis factor (TNF) and interleukin-1 (IL-1) than either peripheral blood monocytes from the same patients or alveolar macrophages from the patients with nonmalignant disorders. These results are consistent with either different regulatory pathways for cytotoxicity and cytokine secretion in the alveolar macrophages of patients with lung cancer or diversity in the subpopulations of cells responsible for these functions.
Collapse
Affiliation(s)
- K P Siziopikou
- Section of Medical Oncology, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612
| | | | | | | | | |
Collapse
|
39
|
Abstract
We have isolated cDNA clones for the gene, termed GPX1, encoding the major human selenoprotein, glutathione peroxidase. Sequence analysis confirmed previous findings that the unusual amino acid seleno-cysteine is encoded by the opal terminator codon UGA. Southern blot analysis of human genomic DNA with the GPX1 cDNA showed that restriction endonucleases without sites in the probe sequence produced three hybridizing bands at standard stringency, diminishing to one strongly and one weakly hybridizing band at high stringency. In situ hybridization localized the human GPX1 gene to a single site on chromosome 3, at region 3q11-13.1. Thus, three genomic sites bear sequence homology to the GPX1 cDNA, and the one most homologous maps to 3q11-13.1.
Collapse
Affiliation(s)
- S Chada
- Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655
| | | | | | | |
Collapse
|
40
|
Abstract
Four amber fragments of the recombination-promoting P22 Erf protein were characterized. The intact Erf monomer contains 204 amino acids. The amber mutations produce fragments of 190, 149, 130 and 95 amino acid residues, all of which are inactive in vivo. The 190 residue fragment is more susceptible to proteolysis in cell extracts than is intact Erf. It breaks down to a stable remnant that is slightly larger than the 149 residue fragment. The 149 and 130 residue fragments are stable; electron microscopy of the purified fragments reveals that they have similar morphologies, retaining the ring-like oligomeric structure, but lacking the tooth-like protruding portions of intact Erf. Intact Erf and the 149 residue fragment have similar affinities for single-stranded DNA; the affinity of the 130 residue fragment is 40-fold lower in low salt at pH 6.0. The 95 residue fragment is unstable in vivo. These observations, combined with previous observations, are interpreted as suggesting that the boundary of the amino-terminal domain of the protein lies between residues 96 and 130, that certain residues between 131 and 149 form part of an interdomain DNA-binding segment of the protein, that the boundary of the carboxy-terminal domain lies to the C-terminal side of residue 149, and that the carboxy-terminal domain is not necessary for assembly of the ring oligomer, although it is essential for Erf activity in vivo.
Collapse
|
41
|
Golembiewski RT, Andrew GM, Bauder M, Boss LS, Boss RW, Burke RJ, Cahoon A, Carrigan DC, Casey L, Corbett JM. The epidemiology of progressive burnout: a primer. J Health Hum Resour Adm 1987; 9:16-37. [PMID: 10279826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
42
|
Abstract
Hypothermia occurs frequently in the critically ill patient, yet little is known about the endogenous catecholamine response to this stress. To study this problem, we measured heart rate (HR), mean arterial blood pressure (MAP), and plasma levels of norepinephrine (NE) and epinephrine (Epi) in subhuman primates (baboons) during progressive hypothermia from 37 degrees to 29 degrees C and then during rewarming to 37 degrees C. As the core temperature decreased from 37 degrees to 33 degrees C, HR and MAP increased significantly (p less than 0.05), but as core temperature further decreased from 33 degrees to 29 degrees C, the HR and MAP fell to prehypothermic levels. Plasma concentrations of NE and Epi increased significantly (p less than 0.01) as core temperature fell from 37 degrees to 31 degrees C, but as core temperature dropped from 31 degrees to 29 degrees C, plasma NE and Epi levels decreased towards prehypothermic concentrations. These findings indicate that the sympathetic nervous system (SNS) responds quickly to hypothermia but may be "switched off" at a threshold temperature of about 29 degrees C. We speculate that hypotensive patients with temperatures less than or equal to 29 degrees C may benefit from infusions of exogenous catecholamines, especially if there have been only minimal benefits achieved with conventional therapy such as fluids, and an increase in ambient temperature.
Collapse
|
43
|
Abstract
Messenger RNA half-life in vegetatively growing cells of Dictyostelium discoideum was determined using a uridine pulse-chase procedure. In these experiments, mRNA decayed in a complex fashion, and consisted of at least two major components, one with a half-life of about 50 min and a second with a half-life of about 10 hr. These results independently confirm our previous studies on the decay of mRNA extracted from actinomycin D-treated cells. Since these results were in apparent conflict with half-life determinations obtained with a combination of actinomycin D and daunomycin (J. P. Margolskee and H. F. Lodish, 1980a, Dev. Biol. 74, 37-49), we have also studied mRNA half-life in cells treated with a combination of both drugs and found that simultaneous use of both drugs leads to accelerated mRNA decay and other noticeable side effects. In light of our observations, we have suggested an alternative to conclusions drawn by others with respect to mRNA synthesis and stability in Dictyostelium development.
Collapse
|
44
|
Chernow B, Lake CR, Cruess D, Coyle J, Hughes P, Balestrieri F, Casey L, Rainey TG, Fletcher JR. Plasma, urine, and CSF catecholamine concentrations during and after ketamine anesthesia. Crit Care Med 1982; 10:600-3. [PMID: 7105769 DOI: 10.1097/00003246-198209000-00009] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Ketamine has been reported to increase plasma catecholamine concentrations. Prior investigations have only studied plasma catecholamine levels for short periods after iv ketamine. Because ketamine is one of the most frequently used anesthetic agents in critical care research, we evaluated ketamine's effect on catecholamines over a longer period of time. Plasma, urine, and CSF epinephrine (E) and norepinephrine (NE) concentrations were serially measured during a 2-h ketamine infusion and a subsequent 2-h "wake-up" period. No changes in heart rate, mean arterial blood pressure or urine, plasma, and CSF NE concentrations were noted during the 4-h study period, whereas there were significant (p less than 0.005) increases in urine, plasma, and CSF E levels during ketamine infusion but not during the wake-up period. An unexpected finding was that the baboons have very high basal plasma E levels versus those in humans. It is concluded that ketamine is a useful anesthetic agent for critical care research involving measurements of sympathetic nervous system activity. The interesting observation of high plasma levels in the baboon warrants further investigation.
Collapse
|
45
|
Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med 1981; 9:651-4. [PMID: 6268354 DOI: 10.1097/00003246-198109000-00008] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Serum angiotensin converting enzyme (ACE) levels were obtained in 24 control patients who were critically ill, in 11 patients with cardiogenic pulmonary edema, in 8 patients with status postcardiopulmonary bypass, and in 12 patients with adult respiratory distress syndrome (ARDS). Mean values in cardiogenic pulmonary edema (24.3 +/- 3.9 SD) in cardiopulmonary bypass (19.5 +/- 3.1) and in patients with ARDS and no sepsis (n = 7, 19.0 +/- 5.5) were not significantly different from controls (20.7 +/- 2.8). In contrast, patients with ARDS and sepsis had markedly decreased serum ACE levels which fell outside of control range (n = 5, 8.6 +/- 2.3). The authors speculate that decreased ACE levels in the combination of sepsis and ARDS are due to the presence of circulating inhibitors of ACE. The finding of decreased serum ACE can be of potential clinical usefulness by raising the possibility of sepsis as the etiology of ARDS before results of blood cultures are available.
Collapse
|
46
|
Hersh LB, Coe B, Casey L. A fluorometric assay for choline acetyltransferase and its use in the purification of the enzyme from human placenta. J Neurochem 1978; 30:1077-85. [PMID: 660185 DOI: 10.1111/j.1471-4159.1978.tb12401.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|